+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Ursodiol and interferon alfa-2B for the treatment of chronic hepatitis C



Ursodiol and interferon alfa-2B for the treatment of chronic hepatitis C



Gastroenterology 104(4 Suppl. ): A966




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 034144975

Download citation: RISBibTeXText


Related references

Interferon alfa 2B and ursodiol combination therapy in management of chronic hepatitis C. Gastroenterology 112(4 Suppl. ): A1364, 1997

Lymphoblastoid interferon alfa-n1 improves the long-term response to a 6-month course of treatment in chronic hepatitis C compared with recombinant interferon alfa-2b: results of an international randomized controlled trial. Clinical Advisory Group for the Hepatitis C Comparative Study. Hepatology 27(4): 1121-1127, 1998

Treatment of Chronic Hepatitis due to Hepatitis C Virus (CH-C) in India: A Randomized Controlled Trial Comparing Daily Interferon-alfa-2b and Ribavirin with Daily Interferon-alfa-2b and Glycyrrhizin-A Multicenter Study. Journal of Clinical and Experimental Hepatology 2(1): 10-18, 2012

Safety and efficacy of interferon-alfa and interferon-alfa plus ribavirin for the treatment of chronic hepatitis C in HIV-infected patients under HAART. Hepatology 32(4 Pt 2): 555A, 2000

Non a non b chronic hepatitis not responding to a standard interferon alfa treatment doubling interferon alfa dosage has marginal efficacy. Journal of Hepatology 13(Suppl. 2): S77, 1991

A randomized, double-blind trial comparing pegylated interferon alfa-2b to interferon alfa-2b as initial treatment for chronic hepatitis C. Hepatology 34(2): 395-403, 2001

A comparative randomized controlled study of the efficacy of interferon alfa-2b and interferon alfa-2a in the treatment of chronic hepatitis C. Gastroenterologia Y Hepatologia 18(2): 66-72, 1995

Alfa interferon 2B and ribavirin for treatment of patients with chronic hepatitis C who have failed alfa interferon 2B as single therapy. Hepatology 28(4 Part 2): 284A, 1998

Ribavirin plus alfa interferon in the treatment of chronic hepatitis C unresponsive to alfa interferon alone Evaluation of response in terms of ALT values and quantitative viraemia. Hepatology 24(4 Part 2): 483A, 1996

A randomized, double blind, placebo controlled trial of interferon-alfa and amantadine versus interferon-alfa alone in the treatment of chronic hepatitis C. Gastroenterology 118(4 Suppl 2 Part 2): AASLD A148, 2000

A randomized study of Ribavirin plus interferon alfa vs interferon alfa alone for treatment of patients with chronic hepatitis C. Hepatology 30(4 Part 2): 621A, 1999

Natural alfa interferon treatment of chronic hepatitis C in patients refractory to recombinant interferon alfa 2B. Hepatology 22(4 Part 2): 117A, 1995

The retreatment with natural leukocyte interferon alfa-n3 of chronic hepatitis C patients: the intolerant and nonresponsive results to prior treatment with recombinant alfa interferon. Annali Italiani di Medicina Interna 14(3): 159-165, 1999

A controlled, randomized, multicenter, descending dose phase II trial of pegylated interferon alfa-2a vs standard interferon alfa-2a for treatment of chronic hepatitis C. Gastroenterology 116(4 Part 2): A1275, 1999

Pegylated interferon alfa-2b monotherapy is superior to interferon alfa-2b for the treatment of chronic hepatitis C. Journal of Hepatology 32(Suppl. 2): 29, 2000